IFNG and cancer: •RT‐enhanced CTLs provides feedback loop to cancer cells to upregulate PD‐L1 via IFN‐γ‐JAK/STAT1 pathway•RT‐upregulation of IL‐6 in TME enhances PD‐L1 expression•RT may upregulate PD‐1 on T cells